US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 108.730
  • -1.910-1.73%
Close Nov 11 16:00 ET
  • 108.730
  • 0.0000.00%
Post 20:01 ET
26.07BMarket Cap-52602P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioNTech Q3 2024 Earnings Date

Currency：EURNov 4, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
516.02M
1.24B
+728.78M
Beat Est.
-42.36%
+39.04%
+141.23%
EPS
-1.70
0.81
+2.51
Beat Est.
-354.39%
+22.73%
+147.52%
Analyst Rating
Buy

Nov 8, 2024

BioNTech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
May 5, 2025 2025/Q1 -- / 211.333M --
-- 2024/Q4 -- / 1.151B --
Nov 4, 2024 2024/Q3 1.245B / 516.021M --
Aug 5, 2024 2024/Q2 128.700M / 135.687M --
May 6, 2024 2024/Q1 187.600M / 372.284M --
DatePeriodRevenue/EstimateEarnings Call
May 5, 20252025/Q1-- / 211.333M--
--2024/Q4-- / 1.151B--
Nov 4, 20242024/Q31.245B / 516.021M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--

Unlock Free Earnings Estimates

BioNTech Earnings Reports

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 4 19:59

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 4 19:59

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5 18:37

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5 18:37

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Buy

    • Buy

      62.50%

    • Hold

      37.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Infectious Disease
    Infectious Disease
    Intraday-0.59%